Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation

Ayanoglu, Muge; Korgali, Elif; Sezer, Taner; Aydin, Halil; Sonmez, Fatma

doi:10.1016/j.braindev.2020.02.001

Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation

Atıf İçin Kopyala

Ayanoglu M., Korgali E., Sezer T., Aydin H. I. , Sonmez F. M.

BRAIN & DEVELOPMENT, cilt.42, ss.418-420, 2020 (SCI İndekslerine Giren Dergi)

Cilt numarası: 42 Konu: 5
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.braindev.2020.02.001
Dergi Adı: BRAIN & DEVELOPMENT
Sayfa Sayıları: ss.418-420

Özet

We describe the first child with guanidinoacetate methyltransferase (GAMT) deficiency who developed neuroleptic malignant syndrome (NMS) after the treatment of risperidone without elevated creatine kinase (CK) levels.